**Executive Summary**
The Prime Minister launched a nationwide Human Papillomavirus (HPV) Vaccination Campaign targeting 14-year-old girls across India, starting in Ajmer, Rajasthan. The goal is to prevent cervical cancer, a significant health concern in India, through a voluntary, free, single-dose vaccine administered at government health facilities. The campaign is set to run for 3 months, until end of May 2026.
**Key Points / Main Content**
* **Vaccination Campaign Details:**
* Aims to vaccinate 1.2 crore 14-year-old girls annually.
* Uses Gardasil-4 (quadrivalent) HPV vaccine (types 6, 11, 16, 18) in a single dose.
* Voluntary and free of cost, administered after parental/guardian consent.
* Will be available on routine immunization days after the campaign phase.
* **Administration and Logistics:**
* Administered intramuscularly (IM) in the left upper arm (0.5 ml dose).
* Vaccination sessions are held at Government Health Facilities.
* Beneficiaries can pre-register on the U-WIN digital platform or opt for walk-in vaccination.
* Parental/guardian consent is mandatory and recorded digitally on U-WIN or via hard copy where internet is unavailable.
* U-WIN platform manages session planning, registration, recording, and reporting.
* e-VIN portal manages vaccine stocks and logistics.
* **Eligibility and Deferral:**
* Target population: Girls who have completed 14 years but have not yet completed 15 years.
* Vaccination will be deferred for girls with moderate or severe illness until recovery, a history of severe allergic reaction to previous vaccination, known allergies to yeast, or those outside the target age group.
* Vaccination status of girls who have already received any HPV vaccine will be updated on the U-WIN portal.
* **National and International Support:**
* HPV vaccination is validated and recommended by global and national expert bodies like WHO and NTAGI.
* 160 out of 194 countries have introduced HPV vaccine under their National Immunization Programmes.
**Impact Analysis**
**Stakeholder: 14-Year-Old Girls**
* **Impact:** Protected against HPV infection and cervical cancer.
* **Action Required:** Receive the HPV vaccine during the campaign period after parental/guardian consent.
**Stakeholder: Parents/Guardians**
* **Impact:** Opportunity to protect their daughters from cervical cancer.
* **Action Required:** Provide consent for their 14-year-old daughters to receive the HPV vaccine.
**Stakeholder: Government Health Facilities**
* **Impact:** Responsible for administering the HPV vaccine.
* **Action Required:** Implement the vaccination campaign, ensuring adequate vaccine supply, trained personnel, and adherence to guidelines.
**Stakeholder: States and Union Territories**
* **Impact:** Must align with central guidelines.
* **Action Required:** Ensure seamless implementation of the HPV vaccination campaign within their jurisdictions.
**Stakeholder: Ministry of Health and Family Welfare**
* **Impact:** Launch of a national program against Cervical Cancer
* **Action Required:** Implementation of HPV Vaccination drive across the nation.
Key Entities Referenced
Nationwide HPV Vaccination Campaign: A government initiative to provide HPV vaccination to 14-year-old girls across India to prevent cervical cancer.
Human Papillomavirus (HPV) Vaccine: The vaccine being administered in the campaign to prevent cervical cancer.
Ministry of Health and Family Welfare: The primary government body responsible for overseeing and implementing the HPV vaccination campaign.
U-WIN digital platform: The digital platform used for pre-registration, appointment scheduling, and recording vaccination data for the HPV vaccination campaign.
Ajmer, Rajasthan: Location of the launch event for the Nationwide HPV Vaccination Campaign.
Ministry of Health and Family Welfare
Prime Minister Shri Narendra Modi Launches
Nationwide HPV Vaccination Drive for 14-Year-
Old Girls from Ajmer, Rajasthan
Major Milestone in India’s Fight Against Cervical Cancer
Voluntary, Free-of-Cost, Single-Dose HPV Vaccines to be
administered after consent at Government Health Facilities
If the mother is healthy, the family remains capable of facing
every crisis. With this sentiment the government has run
many schemes to provide support to women: Prime Minister
Clean Fuel, Sanitation and Nutrition Support Mark New Era of
Sensitivity in Women’s Health: Prime Minister
Posted On: 28 FEB 2026 3:36PM by PIB Delhi
Hon’ble Prime Minister Shri Narendra Modi today launched the nationwide Human Papillomavirus
(HPV) Vaccination Campaign for 14-year-old girls from Ajmer, Rajasthan, marking a historic milestone in
India’s fight against cervical cancer.Union Health Minister Shri Jagat Prakash Nadda joined the event virtually from Kartavya Bhawan in the
presence of Smt. Anupriya Patel, Union MoS for Health and Family Welfare; Dr V K Paul, Member
(Health), NITI Aayog and senior officials of the Union Health Ministry. Dr M Srinivas, Director, AIIMS
New Delhi; Dr Sandeep Bansal, Director, Safdarjung Hospital and senior officials and doctors from
AIIMS New Delhi, Safdarjung Hospital, RML Hospital and Lady Hardinge Medical College were also
present on the occasion.
Speaking on the occasion, the Prime Minister described the nationwide HPV vaccination campaign as a
pivotal step toward empowering India’s ‘Nari Shakti’ and safeguarding the health of mothers and
daughters across the country. “We all know that when a mother falls ill in the family, the house feels
scattered. If the mother is healthy, the family remains capable of facing every crisis. With this sentiment
the government has run many schemes to provide support to women,” he highlighted.अजमेर से HPV vaccination अभयान शुरू हुआ ह।
ये अभयान दश क नारीशक्त को सशक्त करने क दशा म अहम कदम ह: PM @narendramodi
— PMO India (@PMOIndia) February 28, 2026
Emphasising the Government’s sensitive and mission-driven approach to women’s health and dignity, the
Prime Minister referred to transformative interventions such as large-scale toilet construction under
sanitation initiatives, provision of affordable sanitary pads and the Pradhan Mantri Ujjwala Yojana, which
has ensured clean cooking fuel for millions of households.
He also spoke about the safe motherhood scheme under which ₹5,000 is directly transferred into the bank
accounts of expectant mothers to support nutritious food during pregnancy. The Prime Minister underlined
that these initiatives reflect a shift from a culture of neglect to one rooted in care, dignity and sensitivity
towards women’s health and well-being.
The national launch event in Ajmer witnessed virtual participation from all States and Union Territories.
Hon’ble Governors, Hon’ble Chief Ministers, Hon’ble Deputy Chief Ministers, Hon’ble Administrator,
Hon’ble State Health Ministers, Hon’ble Education Minister, along with Additional Chief Secretaries,
Principal Secretaries, Secretaries and senior health officials joined from their respective State/UT
headquarters.
Cervical cancer remains a significant public health concern globally and in India. It is the second most
common cancer among women in India, with over 1 lakh 20 thousand new cases and nearly 80 thousand
deaths reported annually as per the WHO GLOBOCAN report 2022. Persistent infection with high-risk
Human Papillomavirus (HPV) types, particularly types 16 and 18 – has been established as the primary
cause of cervical cancer.
The nationwide HPV vaccination campaign aims to prevent cervical cancer by protecting girls before
potential exposure to HPV infection. The vaccine is safe, effective and provides long-lasting protection
against HPV strains responsible for the majority of cervical cancer cases.HPV vaccination has been validated and recommended by global and national expert bodies including the
World Health Organization (WHO) and India’s National Technical Advisory Group on Immunization
(NTAGI).
Globally 160 out of 194 countries have introduced HPV vaccine under their National Immunization
Programmes. 90 countries have adopted a single-dose schedule, including majority of Southeast Asian
countries. 80 countries are using Gardasil-4 vaccine in their National Immunization Programme. Out of
these, 61 countries are implementing a single-dose schedule of Gardasil-4.
HPV vaccines are 93–100% effective in preventing cervical cancer caused by vaccine-covered HPV types.
Evidence also shows a strong herd effect – high vaccination coverage reduces circulation of HPV strains,
thereby providing indirect protection even to unvaccinated individuals.
India’s national programme uses Gardasil-4 (Quadrivalent: HPV types 6, 11, 16, 18) in a single-dose
schedule, aligned with global scientific evidence and WHO recommendations.
Target Population and Coverage:
The campaign will cover girls aged 14 years (those who have completed 14 years but have not yet
completed 15 years). As per Registrar General of India (RGI) 2021 estimates, the annual cohort of 14-
year-old girls is approximately 1.2 crore, who are expected to benefit from this initiative each year.
Operational Plan of the HPV Vaccination Campaign:
The introduction of HPV vaccination in India has been meticulously planned with detailed attention to
safety, logistics and monitoring.
Key Features:
Vaccination Duration: 3 months (90 days) in campaign mode.
After completion of the campaign phase, HPV vaccine will be available on routine immunization session
days.
Session Sites: Only Government Health Facilities like Ayushman Arogya Mandir (AAM) – Primary Health
Centres (PHCs), Community Health Centres (CHCs), Sub-District Hospitals (SDHs), District Hospitals
(DHs), Government Medical Colleges and Hospitals (GMCHs)
Dose & Administration: Single dose (0.5 ml) Intramuscular (IM) injection in the left upper arm
Vaccination is voluntary, free of cost and will be administered only after parental/guardian consent.
Beneficiaries may pre-register and schedule appointments on the U-WIN digital platform, or opt for walk-
in vaccination at designated government health facilities. Parental/guardian consent is mandatory and will
be recorded digitally on U-WIN. In areas without internet connectivity, consent may be obtained in hard
copy as per prescribed format.
The U-WIN platform will be used for session planning, registration, recording and reporting, while the e-
VIN portal will manage vaccine stocks and logistics.
Extensive preparatory activities, including nationwide capacity-building exercises covering all technical
and operational aspects, have been undertaken. Detailed guidelines have been shared with all States and
Union Territories to ensure seamless implementation.
The programme follows strict medical guidelines. Vaccination will be deferred or avoided in the following
cases:
Girls with moderate or severe illness until recovery
Girls with a history of severe allergic reaction to previous vaccinationGirls known to be allergic to yeast
Girls outside the target age group
For girls who have already received any HPV vaccine (Gardasil, Gardasil-9, Cervarix, or Cervavac), their
vaccination status will be updated on the U-WIN portal.
All vaccination sessions are conducted under supervision of trained Medical Officers, with functional
Cold Chain Points (CCPs) and linkage to 24×7 government health facilities for management of any rare
Adverse Events Following Immunization (AEFI).
Following the Prime Minister’s national launch, HPV vaccination campaign launches were held across all
States and Union Territories through local events.
The nationwide HPV vaccination campaign represents a transformative step in India’s preventive
healthcare strategy and reflects delivery-oriented governance rooted in scientific evidence and
implementation readiness.
The Union Ministry of Health and Family Welfare urges parents and guardians to ensure that their 14-
year-old daughters receive the HPV vaccine during the campaign period. HPV vaccination is a powerful
preventive intervention that can save lives and secure a healthier, cancer-free future for India’s daughters.
***
Dr. Sanjay Roy/Anand Chaturvedi
HFW/PM Launch of HPV Vaccination/28th February 2026/1
(Release ID: 2233906) Visitor Counter : 3050
Read this release in: Kannada , Malayalam , Urdu , Marathi , ही , Punjabi , Tamil